Rexahn Pharmaceuticals (REXN) Stock Price, Quote, News and Overview
NASDAQ:REXN - Nasdaq -
REXN Quote, Performance and Key Statistics
1.81
-0.06 (-3.21%)
The current stock price of REXN is 1.81 null. In the past month the price decreased by -17.35%. In the past year, price increased by 0.56%.
About REXN
Company Profile
REXAHN PHARMACTICALS is a biopharmaceutical company leveraging its proprietary technology platform to discover, develop and commercialize innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs. Rexahn's compounds are designed to uniquely treat various disease states while significantly minimizing side effects in order to allow patients to regain quality of life through therapy.
Company Info
Rexahn Pharmaceuticals
15245 SHADY GROVE ROAD SUITE 455
ROCKVILLE MD 20850
CEO: Douglas J. Swirsky
Phone: 240-268-5300
Rexahn Pharmaceuticals / REXN FAQ
What is the stock price of Rexahn Pharmaceuticals today?
The current stock price of REXN is 1.81 null. The price decreased by -3.21% in the last trading session.
What is the ticker symbol for Rexahn Pharmaceuticals stock?
The exchange symbol of Rexahn Pharmaceuticals is REXN and it is listed on the Nasdaq exchange.
On which exchange is REXN stock listed?
REXN stock is listed on the Nasdaq exchange.
What is Rexahn Pharmaceuticals worth?
Rexahn Pharmaceuticals (REXN) has a market capitalization of 8.11M null. This makes REXN a Nano Cap stock.
What are the support and resistance levels for Rexahn Pharmaceuticals (REXN) stock?
Rexahn Pharmaceuticals (REXN) has a support level at 1.8 and a resistance level at 2.04. Check the full technical report for a detailed analysis of REXN support and resistance levels.
Should I buy Rexahn Pharmaceuticals (REXN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of REXN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of REXN, evaluating the profitability, health, valuation and growth aspects
- Rexahn Pharmaceuticals (REXN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Rexahn Pharmaceuticals (REXN) Sales and EPS estimates to see what analysts future expectations are.
- Rexahn Pharmaceuticals (REXN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Rexahn Pharmaceuticals (REXN) Insider and Institutional Ownership to learn about the owners and their transactions.
- Rexahn Pharmaceuticals (REXN) Stock Chart to make your own analysis
- Rexahn Pharmaceuticals (REXN) Latest news and press-releases to stay up to date.
Does Rexahn Pharmaceuticals (REXN) stock pay dividends?
REXN does not pay a dividend.
What is the Price/Earnings (PE) ratio of Rexahn Pharmaceuticals (REXN)?
Rexahn Pharmaceuticals (REXN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.41).
REXN Technical Analysis
REXN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to REXN. REXN may be in some trouble as it scores bad on both profitability and health.
REXN Financial Highlights
Over the last trailing twelve months REXN reported a non-GAAP Earnings per Share(EPS) of -1.4100000000000001. The EPS increased by 25.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -553.95% | ||
| ROA | -72.11% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |